| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Reviewers 2023
|
|
|
|
42 |
9 |
p. 2485-2493
|
artikel
|
| 2 |
A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole
|
Sirek, Greta
|
|
|
42 |
9 |
p. 2127-2134
|
artikel
|
| 3 |
Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination – A self-controlled case series analysis
|
Morgan, Hannah J.
|
|
|
42 |
9 |
p. 2212-2219
|
artikel
|
| 4 |
A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice
|
Beavis, Ashley C.
|
|
|
42 |
9 |
p. 2347-2356
|
artikel
|
| 5 |
An inactivated whole-virion vaccine for Enterovirus D68 adjuvanted with CpG ODN or AddaVax elicits potent protective immunity in mice
|
Senpuku, Kota
|
|
|
42 |
9 |
p. 2463-2474
|
artikel
|
| 6 |
A paired measles-rubella catch-up campaign in Sichuan China to stop an outbreak and strengthen local immunization programs
|
Liu, Jiajie
|
|
|
42 |
9 |
p. 2155-2160
|
artikel
|
| 7 |
Association of COVID-19 vaccination with duration of hospitalization in older adults in Hong Kong
|
Chen, Dongxuan
|
|
|
42 |
9 |
p. 2385-2393
|
artikel
|
| 8 |
Benefit–risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373)
|
Fix, Jonathan
|
|
|
42 |
9 |
p. 2161-2165
|
artikel
|
| 9 |
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adults
|
Karras, Joshua
|
|
|
42 |
9 |
p. 2407-2413
|
artikel
|
| 10 |
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
|
Faksova, K.
|
|
|
42 |
9 |
p. 2200-2211
|
artikel
|
| 11 |
Current vaccine strategies and novel approaches to combatting Francisella infection
|
Harrell, Jaikin E.
|
|
|
42 |
9 |
p. 2171-2180
|
artikel
|
| 12 |
Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of care
|
Yashar-Gershman, Sarah G.
|
|
|
42 |
9 |
p. 2260-2270
|
artikel
|
| 13 |
Differences in social media use by COVID-19 vaccination status
|
Moffett, Kenneth W.
|
|
|
42 |
9 |
p. 2166-2170
|
artikel
|
| 14 |
Editorial Board
|
|
|
|
42 |
9 |
p. ii
|
artikel
|
| 15 |
Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection
|
Duan, Xiaoxia
|
|
|
42 |
9 |
p. 2317-2325
|
artikel
|
| 16 |
Effectiveness of inactivated COVID-19 vaccine CoronaVac in children aged less than 3 years old during Omicron wave in Hong Kong
|
Wong, W.H.S.
|
|
|
42 |
9 |
p. 2135-2137
|
artikel
|
| 17 |
Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 – December 2019
|
Merdrignac, Lore
|
|
|
42 |
9 |
p. 2370-2379
|
artikel
|
| 18 |
Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents
|
Levin, Myron J.
|
|
|
42 |
9 |
p. 2278-2281
|
artikel
|
| 19 |
Establishing priorities to strengthen National Immunization Technical Advisory Groups in Latin America and the Caribbean
|
Evans-Gilbert, Tracy
|
|
|
42 |
9 |
p. 2310-2316
|
artikel
|
| 20 |
Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia
|
Maldonado, Ivette
|
|
|
42 |
9 |
p. 2414-2420
|
artikel
|
| 21 |
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial
|
Gilbert, Peter B.
|
|
|
42 |
9 |
p. 2181-2190
|
artikel
|
| 22 |
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study
|
Raethke, Monika
|
|
|
42 |
9 |
p. 2357-2369
|
artikel
|
| 23 |
High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains
|
Opmeer, Lizet
|
|
|
42 |
9 |
p. 2475-2484
|
artikel
|
| 24 |
Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18–60 years: A double-blind, non-inferiority, randomized controlled trial
|
Yadegarynia, Davood
|
|
|
42 |
9 |
p. 2254-2259
|
artikel
|
| 25 |
Influences of mpox disease perceptions, sources and contents of information exposure on mpox vaccine uptake among gay, bisexual, and other men who have sex with men in Hong Kong, China
|
Cheung, Doug H.
|
|
|
42 |
9 |
p. 2337-2346
|
artikel
|
| 26 |
Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice
|
St-Louis, Philippe
|
|
|
42 |
9 |
p. 2144-2149
|
artikel
|
| 27 |
Investigation on the correlation factors of positive Streptococcus pneumoniae antibody and IgG antibody level of Streptococcus pneumoniae in the elderly over 60 years old in Shenzhen
|
Su, Lixian
|
|
|
42 |
9 |
p. 2448-2454
|
artikel
|
| 28 |
Landscaping analysis of immunization progress and program structures in selected middle income Southeast Asian countries
|
Basa, Jessabelle E.
|
|
|
42 |
9 |
p. 2326-2336
|
artikel
|
| 29 |
Migration and infant immunization timeliness in New Zealand: Evidence from the Growing Up in New Zealand study
|
Hashemi, Ladan
|
|
|
42 |
9 |
p. 2229-2238
|
artikel
|
| 30 |
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1
|
Lasrado, Ninaad
|
|
|
42 |
9 |
p. 2117-2121
|
artikel
|
| 31 |
Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant
|
Marques, Rodolfo F.
|
|
|
42 |
9 |
p. 2394-2406
|
artikel
|
| 32 |
Pandemic antecedents – Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination
|
Luisi, Monique
|
|
|
42 |
9 |
p. 2455-2462
|
artikel
|
| 33 |
Parental willingness to accept and pay human papillomavirus vaccine for boys aged 9–14 in a metropolis area of China: Evidence for developing a vaccination strategy
|
Zhou, Weiyu
|
|
|
42 |
9 |
p. 2246-2253
|
artikel
|
| 34 |
Partisan divide and Racial/Ethnic disparities in COVID-19 vaccine hesitancy among Parents/Guardians and vaccine uptake among children in the U.S.
|
Shijia Yan, Alice
|
|
|
42 |
9 |
p. 2150-2154
|
artikel
|
| 35 |
Pilot-scale production of a highly efficacious and stable monoglycosylated influenza split virus vaccine
|
Wu, Chia-Ying
|
|
|
42 |
9 |
p. 2220-2228
|
artikel
|
| 36 |
Prevalence, serogroup distribution and risk factors of Neisseria meningitidis carriage in high school and university students in Hungary
|
Huber, Annamária
|
|
|
42 |
9 |
p. 2271-2277
|
artikel
|
| 37 |
Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine
|
Kohli, Michele
|
|
|
42 |
9 |
p. 2282-2289
|
artikel
|
| 38 |
Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL/6 mice
|
Hasan, Tanjila
|
|
|
42 |
9 |
p. 2299-2309
|
artikel
|
| 39 |
Region-wide assessment of National Immunization Technical Advisory Groups (NITAGs) using the NITAG Maturity Assessment Tool (NMAT) – Experience from the Eastern Mediterranean Region of the World Health Organization, 2023
|
Sume, Gerald Etapelong
|
|
|
42 |
9 |
p. 2239-2245
|
artikel
|
| 40 |
Reply to letter to editor by Yin et al.
|
Gärtner, B.C.
|
|
|
42 |
9 |
p. 2115-2116
|
artikel
|
| 41 |
Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial
|
Su, Yu-Wen
|
|
|
42 |
9 |
p. 2438-2447
|
artikel
|
| 42 |
Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial
|
Zaman, Khalequ
|
|
|
42 |
9 |
p. 2290-2298
|
artikel
|
| 43 |
Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System – United States, September 1, 2022 – March 31, 2023
|
Moro, Pedro L.
|
|
|
42 |
9 |
p. 2380-2384
|
artikel
|
| 44 |
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022
|
Meng, Lu
|
|
|
42 |
9 |
p. 2122-2126
|
artikel
|
| 45 |
The Vaccine Training Barometer: Assessing healthcare providers’ confidence to answer vaccine-related questions and their training needs
|
De Waele, Aurélie
|
|
|
42 |
9 |
p. 2421-2428
|
artikel
|
| 46 |
Transformative vaccination: A pentavalent shield against COVID-19 and influenza with betulin-based adjuvant for enhanced immunity
|
Krasilnikov, Igor
|
|
|
42 |
9 |
p. 2191-2199
|
artikel
|
| 47 |
Vaccination during pregnancy and modulation of IgG response to pertussis vaccines in infants: The impact of different vaccine formulations
|
Brousseau, Nicholas
|
|
|
42 |
9 |
p. 2138-2143
|
artikel
|
| 48 |
Virus-like particles of louping ill virus elicit potent neutralizing antibodies targeting multimers of viral envelope protein
|
Tandavanitj, Rapeepat
|
|
|
42 |
9 |
p. 2429-2437
|
artikel
|
Tijdschrift beschrijving